President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Novo Nordisk (NVO) said its popular diabetes drug Ozempic, or semaglutide, has been approved for the treatment of patients ...

Ozempic, or semaglutide, can now be used to reduce the risk of worsening kidney disease or kidney failure in adults with type ...

Stocks to Buy or Sell. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other ...

Shares are mixed in Asia after U.S. stocks edged back from their all-time high, with many regional markets closed for lunar ...

US stocks closed lower afer the S&P 500 touched an intraday record high early in the day. As tariff worries eased, mixed ...

The big hope is that Europe will move faster to implement reforms in the face of competitive threats from the U.S.

The bankers, government officials and CEOs at Davos see his deregulatory, energy and tariff policies sucking investment from ...

(Reuters) - European shares were subdued on Tuesday, as rising financials and healthcare shares countered broader losses ...

European shares held steady with slight gains in financials and healthcare despite global uncertainties over U.S. President Donald Trump's proposed tariffs. The market's cautious optimism was ...